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The clinical features of 24 patients with non-specific interstitial pneumonia (NIP) were evaluated. The patients 
consisted of seven men and 17 women, with a median age of 60 years. In seven patients, the disease was idiopathic 
and eight had collagen vascular diseases. Cough, dyspnoea and fever were frequently observed. The time interval 
between the onset of symptoms and open lung biopsy was 3 months. Mild increases of IgG, CRP, and LDH were 
also frequently observed. The average per cent VC was 65.1 Z!Z 3.2% and the average PaO, was 71.3 + 2.4 Torr. 
Bronchoalveolar lavage was done in 20 patients, and a moderate increase in lymphocytes (27.8 sx 6.7%) with a low 
CD4/CD8 ratio (0.86 f 0.22) was observed. Multiple patchy infiltration or diffuse interstitial shadows, located 
predominantly in the lower fields of both lungs were the characteristic chest CT findings. Lung biopsies in this group 
were characterized by varying proportions of chronic interstitial inflammation and fibrosis which was temporarily 
uniform. Patients were given steroid pulse therapy or oral steroids. The results were mild to marked improvements 
in chest roentgenographic findings and lung functions. Four patients (16.7%) died because of respiratory failure 
caused by NIP. This is the first report to describe clinical features of NIP since the original report by Katzenstein 
and Fiorelli. 
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Introduction 
Idiopathic interstitial pneumonia has been classified into 
three clinical and pathologically distinct types: usual inter- 
stitial pneumonia (UIP), desquamative interstitial pneumo- 
nia (DIP), and acute interstitial pneumonia (AIP) (l-3). A 
number of interstitial pneumonias, however, descriptively 
termed non-specific interstitial pneumonia with fibrosis 
(NIP), cannot be categorized into one of these three types. 
In 1994, Katzenstein and Fiorelli reported the histological 
features and clinical significance of NIP (4). The histologi- 
cal features of NIP include a varying degree of interstitial 
inflammation and fibrosis which appear to develop over a 
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specific time (i.e. the process is temporarily uniform). 
Intra-alveolar accumulation of macrophages and focal 
areas of bronchiolitis obliterans organizing pneumonia 
(BOOP) are occasionally seen, and areas of honeycombing 
are rare (4). 
Katzenstein and Fiorelli reviewed 64 such cases from 
which three histological patterns emerged (4). In 48% of the 
cases, pneumonia was characterized by a cellular interstitial 
infiltrate with little or no fibrosis (NIP group I). This 
pattern probably corresponds to the ‘cellular interstitial 
pneumonia’ described in some patients with rheumatoid 
arthritis (5) and dermatomyositis (6). In 38% of cases, both 
inflammation and fibrosis were seen (NIP group II). In the 
remaining 14% of cases, dense fibrosis was the dominant 
histological feature (NIP group III) (4). 
Recently, Park et al. reported radiographic and CT 
findings in seven patients with NIP (7). In addition, 
Bjoraker et al. reported that patients with UIP have worse 
survival than patients with other types of idiopathic chronic 
interstitial pneumonias including NIP (8). However, clinical 
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features of NIP still remain unclear. Under this back- 
ground, the purpose of this study was to demonstrate the 
clinical features of 24 patients with NIP. 
Materials and Methods 
SUBJECTS 
Between March 1990 and November 1997,24 patients with 
a pathological diagnosis of NIP were entered into this 
study. The patients consisted of seven men and 17 women 
(age range 44474 years; median 60.0 years). There were 15 
non-smokers, two ex-smokers, and seven current smokers. 
No patients have histories of occupational inhalation of 
dust. No patients demonstrated digital clubbing. In auscul- 
tatory findings, inspiratory fine crackles in the back lower 
lung fields were observed in all patients. Since, there were 
no improvements of symptoms and radiological findings 
during the hospital stay, and no antibodies to Tvichosporon 
cutaneum were demonstrated, we believe that patients with 
hypersensitivity pneumonitis were not included in our 
study. 
In all patients, high-resolution computed radiographic 
scanning of the lungs (HRCT) was performed. HRCT was 
performed by making 12 slices from above the aortic arch 
to the diaphragm with 5 mm collimation in a bone detail 
algorithm during moderate inspiration. All subjects under- 
went pulmonary function testing before treatment. Tests of 
spirometry were all performed by the Chestac-25 F system 
(Chest Co., Tokyo, Japan). None of the patients received 
immunosuppressive treatment such as corticosteroid or 
cyclophosphamide at the time of open lung biopsy. The 
diagnoses of pulmonary fibrosis were made on clinical, 
radiological, physiological and histological grounds. In 22 
patients, the diagnosis was made by means of open-lung 
biopsy. Biopsy sites were determined with consideration of 
CT findings. In two patients, NIP was diagnosed in lung 
specimens obtained by autopsy. 
PATHOLOGICAL CRITERIA 
All pathological specimens were analysed by lung pathol- 
ogists (I.Y. and Y.O.) according to the NIP criteria 
described by Katzenstein and Fiorelli (4). Briefly, NIP 
represented a pattern of chronic interstitial pneumonia 
that lacked characteristic features of other specific entities 
such as UIP, DIP, hypersensitivity pneumonitis, BOOP, 
Langerhans’ cell granulomatosis, or chronic eosinophilic 
pneumonia. Lung biopsies in this group were characterized 
by varying proportions of chronic interstitial inflammation 
and fibrosis which is temporarily uniform. This was in 
sharp contrast to the temporarily heterogeneous pattern of 
UIP, related in part to an admixture of recent organization 
(fibroblastic foci) and old collagen-rich scars. 
BLOOD SAMPLES 
Peripheral venous blood samples with and without 
ethylenediaminetetra-acetic acid (EDTA) were obtained 
before breakfast. After centrifugation at 1000 g for 10 min 
at 4°C the serum was frozen and stored at - 70°C until 
used. Arterial blood samples were analysed for PaO, and 
PaCO, using a blood gas analyser. In serum, we measured 
C-reactive protein (CRP), lactate dehydrogenase (LDH), 
and immunoglobulin G (IgG). In peripheral venous blood, 
the white blood cell numbers (WBC) were measured. As a 
pulmonary function test, per cent vital capacity (%VC) and 
forced expiratory volume in 1 s (FEV,%) were measured in 
all patients. Arterial blood gas values (PaO, and PaCO,) 
were also measured. In addition, as a pulmonary function 
test, %C and FEV,% were measured. 
BRONCHOALVEOLAR LAVAGE (BAL) 
Of the 24 patients, BAL was performed in 20. After the 
upper airway was anesthetized with topical lidocaine, a 
flexible fibreoptic bronchoscope was wedged into the lower 
respiratory tract under visualization. To sample the lower 
respiratory tract, BAL was performed by infusing three 
50-ml aliquots of sterile saline at the site of the anterior 
segment of the right lower lobe. The last two aliquots were 
preserved for evaluation. The fluid was filtered through 
gauze, and cells were separated from alveolar lavage fluid 
by centrifugation (300 g for 10 min). BAL fluid (BALF) 
was frozen and stored at - 70°C until used. In BALF, cell 
differentiations and OKT4/OKTS ratios were measured. 
Results 
Table 1 shows the characteristics of 24 patients with NIP. 
There were 17 women and seven men (mean age 60 years). 
Twenty-two patients were diagnosed by open lung biopsy 
and two patients were diagnosed by autopsy. All patients 
were diagnosed with NIP group II according to the 
Katzenstein’s criteria (4). Eight patients had collagen vas- 
cular disorders (rheumatoid arthritis in two, Sjogren’s 
syndrome in two, and dermatomyositis in four). Although 
apparent collagen vascular disorders were not demon- 
strated, autoantibodies (rheumatoid factor, anti-nuclear 
antibody, or anti-Jo-l antibody) were demonstrated in five 
patients. One patient had liver cirrhosis caused by chronic 
hepatitis C virus infection. Among eight patients in whom 
neither collagen vascular diseases nor autoantibodies 
were demonstrated, two patients had underlying diseases 
(ulcerative colitis and history of myeloma). 
Table 2 shows the results of laboratory findings of 24 
patients with NIP. Patients had a relatively high IgG 
(2159 & 333 mg dl-‘), WBC counts (7417 * 610,& ‘), 
CRP (3.0 i 1.0 mg dl- I), and LDH (429 * 46 U 1~ I), 
Fig. 1. Their %VC (65.1 f 3.2%) and PaO, (71.3 +2.4 
Torr) were decreased (Fig. 1). In BALF, an increase of 
lymphocytes (27.8 * 6.7%) and a low CD4/CD8 ratio 
(0.86 & 0.22) were demonstrated (Fig. 2). 
The predominant CT features of NIP were interstitial 
and patchy parenchymal opacification in both lungs, 
predominantly in the middle and lower lung zones. 
Scattered ground-glass opacities were also the most 
common manifestation. Among all patients, neither 
TABLE 1. Patient characteristics 
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Time from onset 
Case Age & sex to biopsy 
No. (years) (M/F) Background Autoantibodies Symptoms at onset (months) 
1 69F 
2 66M 
3 62F 
4 67M 
5 67F 
6 52M 
7 55F 
8 57F 
9 52F 
10 67F 
11 44F 
12 69M 
13 66M 
14 77M 
15 51F 
16 55F 
17 69F 
18 71F 
19 74M 
20 53F 
21 45F 
22 60F 
23 59F 
24 47F 
Bronchiectasis RA (+I Cough, dyspnoea 2 
RA (+I Cough; fever, dyspnoea 2 
Cough, dyspnoea 4 
Ulcerative colitis Cough, dyspnoea 4 
Cough, fever, dyspnoea 1 
Cough, dyspnoea 3 
Dermatomyositis RA (+), ANF (+), Jo-l (+) Dyspnoea 1 
Rheumatoid arthritis RA (+) Cough 5 
RA (+) Cough 2 
Liver cirrhosis RA (+), ANF (+) Cough: dyspnoea 1 
Dermatomyositis ANF (+) Fever, dyspnoea 1 
ANF (+) Cough, dyspnoea 2 
Cough, fever, dyspnoea 2 
Dyspnoea 2 
Cough, fever 2 
RA (+), ANF (+) Cough 7 
Rheumatoid arthritis RA (+), ANF (+) Cough, fever 1 
Sjogren’s syndrome SS-A (+) Cough, dyspnoea 5 
History of myeloma RA (+): SS-A (+) Dyspnoea 2 
Cough, fever, dyspnoea 5 
Dermatomyositis ANF (+) Cough, dyspnoea 6 
Jo-l (+) Cough 1 
Sjogren’s syndrome SS-A (+0) Cough, fever 2 
Dermatomyositis Cough, dyspnoea 8 
honeycombing nor pleural effusions were seen on the initial 
CT scan. 
Table 3 demonstrates the response of therapy and prog- 
nosis of 24 patients with NIP. Steroid therapy was per- 
formed in 21 patients, and steroid plus cyclophosphamide 
was administered in three patients. A good response was 
defined as improvement of PaO, and chest CT findings. A 
poor response was defined as no improvement of both 
PaO, or chest CT findings. Twenty of the 24 patients 
(83.3%) showed good responses. Poor responses were expe- 
rienced in two patients, In two patients, although steroid 
therapy was effective at first, disease became resistant later. 
Four patients (16.7%) died of respiratory failure, and one 
patient died of liver cirrhosis. The clinical courses of four 
patients who died of respiratory failure were 1, 41, 46 and 
91 months, respectively. Apparent honeycomb formation 
was not observed on chest CT either before or after 
treatment in these four patients. 
Discussion 
In our present study, we demonstrated the clinical features 
of 24 patients with NIP (all specimens were diagnosed to be 
NIP group II). 
NIP was first described by Katzenstein and Fiorelli in 
1994 (4). In addition: Park et al. described the radiological 
findings of NIP (7). Furthermore, Bjoraker et al. have 
reported that patients with UIP have worse survival than 
patients with other types of idiopathic chronic interstitial 
pneumonias, including NIP (8). However, the clinical 
features of NIP have not been fully described. 
NIP is not likely to be a single clinicopathological entity. 
In Katzenstein and Fiorelli’s study (4), 16% of the patients 
had an associated collagen vascular disease; 17% had a 
history of inhalational exposure to noxious agents; and 8% 
had a history of recent surgery, severe pneumonia, or 
ARDS. Patients were typically middle-aged women with 
dyspnoea, dry cough, and low-grade fever. The average 
duration of the illness was 3 months. 
There are several new observations in our study. Of 24 
patients with NIP, evidence of underlying connective 
tissue disease was present in eight (33.3%). These included 
rheumatoid arthritis (two), Sjogren’s syndrome (two), and 
dermatomyositis (four). The remaining four patients had 
bronchiectasis, liver cirrhosis, ulcerative colitis and history 
of multiple myeloma, respectively. Interestingly, although 
collagen vascular disorder was not clinically apparent, 
antoantibodies were detected in five patients (rheumatoid 
factor in two, anti-nuclear antibody in one, both rheuma- 
toid factor and anti-nuclear factor in one, and anti-Jo-l 
antibody in one). This evidence strongly suggests that 
the pathological pattern of NIP is closely related to 
autoimmune disorders. 
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TABLE 2. Laboratory data of 24 patients with NIP 
Case 
no. IgG WBC CRP LDH PaO, 
BAL OKT4/ 
%VC FEV,% (LYM) OKT8 
1 1847 5000 ~0.25 408 67 71.3 87.1 
2 2033 8400 12 328 65.7 39.7 77.6 
3 1260 7000 1.7 492 52.9 60.17 94.2 
4 2201 9800 2.8 251 74.9 70.8 91 
5 5756 10 900 4.7 328 42 62.1 84.2 
6 1835.8 8300 0.6 381 91.9 93.3 81.7 
7 1495 9600 1.5 1068 68 73.2 90.6 
8 NA 10 000 5.68 174 81 65.3 88.3 
9 1603 7500 co.25 487 88 56.7 92.9 
10 6960 5000 0.27 287 81 54.2 87.4 
11 2036 2700 2.1 460 84.3 86.3 78.9 
12 1645 4600 0.1 288 78.8 101.1 100 
13 1449 10 900 21.7 441 57.2 NA NA 
14 NA 15 700 8 426 78.1 60.9 85.3 
15 928 6300 0.25 239 74 39.2 83 
16 1330 4100 1.27 254 72 62.1 90 
17 2320 7000 1.71 262 78 84.2 75.3 
18 1780 5500 0.1 506 81.6 60.2 80.1 
19 2087 5000 0.1 286 65.2 57.2 75.9 
20 NA 8300 1.2 778 50 47.7 85.4 
21 1690 10 800 4.18 318 72 53 85.7 
22 1430 5400 0.2 410 68 70.1 90.4 
23 NA 6300 1.1 404 71.6 61.8 72.6 
24 1500 3900 0.2 1019 68.4 65.8 93.8 
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FIG. 1. Results of LDH (U l- I), PaO, (Torr), and %VC in patients with NIP. 
There have been no reports in the English literature 
which have demonstrated laboratory and BALF data of 
NIP. Our data demonstrate elevations of IgG, WBC 
counts, CRP and LDH. Their %VC and PaO, were 
decreased. In BALF, increased lymphocytes and decreased 
OKT4/OKT8 ratios were demonstrated. These findings 
were compatible with BALF findings in pulmonary fibrosis 
associated with collagen vascular disorders. 
As NIP has been described only recently, knowledge of 
its radiographical manifestations is limited (4,7). Both 
. 
0’ 
; 
FIG. 2. Percentage of lymphocytes and OKT4/OKT8 
ratios in BALF in patients with NIP. 
irregular linear opacities and air-space consolidations 
have been described as characteristic features (4,7). In 
addition, the CT features of NIP are the subject of a 
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single report (7). In our study, the predominant CT 
feature was interstitial and patchy parenchymal opacifi- 
cation in both lungs predominantly in the middle and 
lower lung zones. Scattered ground-glass opacities were 
also the most common manifestation. It should be 
stressed that honeycombing was not demonstrated in all 
patients. 
It has been reported that the prognosis for patients with 
this illness was significantly better than that for patients 
with UIP (48). Almost 50% of patients completely recov- 
ered after steroid therapy and the overall mortality was 11% 
(4). In our study, four patients (16.7%) died of respiratory 
failure caused by NIP. The durations of the clinical course 
of the four deceased patients were 1,41, 46 and 91 months, 
respectively. In one of four, serum CA19-9 increased 
according to the deterioration of radiological and clinical 
findings. Importantly, follow-up CT findings demonstrated 
that apparent honeycombing was not demonstrated even 
several years after the onset of the clinical symptoms. This 
is in contrast to UIP. 
The differences between NIP and cryptogenic organizing 
pneumonia should be discussed. Although it is possible to 
differentiate cryptogenic fibrosing alveolitis and NIP by 
pathological findings, the possibility of autoantibody- 
positive cryptogenic fibrosing alveolitis, as described by 
Turner-Warwick et al. (9), should be considered as a 
differential diagnosis of NIP. 
TABLE 3. Therapy and prognosis of 24 patients with NIP 
Case no. Therapy Response Date of OLD? Prognosis 
1 Steroid” 
2 Steroid 
3 Steroid 
4 Steroid 
5 Steroid 
6 Steroid 
7 Steroid+cyclophosphamide 
8 Steroid 
9 Steroid 
10 Steroid 
11 Steroid+cyclophosphamide 
12 Steroid 
13 Steroid 
14 Steroid 
15 Steroid 
16 Steroid 
17 Steroid 
18 Steroid 
19 Steroid 
20 Steroid 
21 Steroid 
22 Steroid 
23 Steroid 
24 Steroid + cyclophosphamide 
Good 3/g/90 
Good*poor 8116190 
Good 1 o/9/90 
Good 4112193 
Good 8124193 
Poor 4127194 
Good 6130194 
Good 9126194 
Good 9121194 
Good 2114195 
Poor Autopsy 
Good 3131195 
Good 4124195 
Good 4126195 
Good 5129195 
Good 612195 
Good 12127195 
Good l/16/96 
Good 2113196 
Good*Poor Autopsy 
Good 6/18/96 
Good 10117196 
Good 11126196 
Good 6125197 
Alive 
Dead (3/24/94) 
Dead (1120198) 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Dead (2/25/96)$ 
Dead (3/28/95) 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Dead (7/19/96)§ 
Dead (2123196) 
Alive 
Alive 
Alive 
Alive 
*Pulse therapy (intravenous methylprednisolone 1000 mg day - ’ for 3 days) was used. 
I-Open lung biopsy; fdied of liver cirrhosis; §died of brain tumour. 
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In summary, our present study demonstrates that NIP as 
presented by Katzenstein and Fiorelli has a distinctive 
clinical entity. The association between NIP with collagen 
lung disease and autoantibodies was clearly demonstrated. 
In addition, we have also confirmed that the prognosis and 
response to corticosteroid is better for NIP than UIP. 
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